tiprankstipranks
William Blair downgrades Applied Therapeutics on revenue uncertainty
PremiumThe FlyWilliam Blair downgrades Applied Therapeutics on revenue uncertainty
2M ago
Applied Therapeutics downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Applied Therapeutics downgraded to Market Perform from Outperform at William Blair
2M ago
Applied Therapeutics price target lowered to $1.50 from $4 at RBC Capital
Premium
The Fly
Applied Therapeutics price target lowered to $1.50 from $4 at RBC Capital
2M ago
Applied Therapeutics Faces FDA Challenges with Govorestat
PremiumCompany AnnouncementsApplied Therapeutics Faces FDA Challenges with Govorestat
3M ago
Applied Therapeutics downgraded to Neutral from Buy at UBS
Premium
The Fly
Applied Therapeutics downgraded to Neutral from Buy at UBS
3M ago
Applied Therapeutics price target lowered to $5 from $14 at Baird
Premium
The Fly
Applied Therapeutics price target lowered to $5 from $14 at Baird
3M ago
Voyager upgraded, HP downgraded: Wall Street’s top analyst calls
PremiumThe FlyVoyager upgraded, HP downgraded: Wall Street’s top analyst calls
3M ago
Voyager rises after upgrade, Applied plunges after CRL: Morning Movers
Premium
The Fly
Voyager rises after upgrade, Applied plunges after CRL: Morning Movers
3M ago
Applied Therapeutics CRL a ‘major setback,’ says William Blair
Premium
The Fly
Applied Therapeutics CRL a ‘major setback,’ says William Blair
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100